Percutaneous ethanol injection therapy in post-transplant patients with secondary hyperparathyroidism

Transplant International

Volumn 20, Issue 12, 2007, Pages 1031-1035

  Douthat, Walter G ^a,b   Orozco, Santiago E ^b   Maino, Pablo ^b   Cardozo, Gabriela ^a   Arteaga, Javier De ^a   Fuente, Jorge De La ^a   Chiurchiu, Carlos R ^a   Massari, Pablo U ^a  

^a UNIVERSIDAD CATÓLICA DE CÓRDOBA   (Argentina)

^b HOSPITAL PRIVADO   (Argentina)

Author keywords

Percutaneous ethanol injection therapy; Renal osteodystrophy; Renal transplant; Secondary hyperparathyroidism

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CREATININE; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE PAIN; CALCIUM BLOOD LEVEL; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; ECHOGRAPHY; FEMALE; HUMAN; HYPERCALCEMIA; HYPOPHOSPHATEMIA; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LOCAL ANESTHESIA; LOCAL THERAPY; MALE; OSTEOPENIA; PARATHYROID HORMONE BLOOD LEVEL; PERCUTANEOUS ETHANOL INJECTION THERAPY; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; THYROID NODULE;

ADULT; ETHANOL; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; INJECTIONS, INTRALESIONAL; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 35748933178     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2007.00545.x     Document Type: Article

References (20)

1. Massari P. Disorders of bone and mineral metabolism after renal transplantation. Kidney Int 1997 52 : 1412.
2. Douthat W, Massari P, Cannata JB. Trastornos del metabolismo óseo y mineral en el trasplante renal. Nefrología 1994 14 : 408.
3. Alsina J, Gonzalez M, Bonnin R, et al. Long-term evolution of renal osteodystrophy after renal transplantation. Transplant Proc 1989 21 : 2151.
4. Messa P, Sindici C, Canella G, et al. Persistent secondary hyperparathyroidism after renal transplantation. Kidney Int 1998 54 : 1704.
5. McCarron D, Muther R, Lenfesty B, et al. Parathyroid function in persistent hyperparathyroidism: relationship to gland size. Kidney Int 1982 22 : 662.
6. Parfitt A. Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cells population control in the parathyroid gland. Miner Electrolyte Metab 1982 8 : 92.
7. Almond N, Kwan J, Evans K, et al. Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron 1994 66 : 52.
8. Julian B, Laskow D, Dubovsky J, et al. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991 325 : 544.
9. Levi M. Post-transplant hypophosphatemia. Kidney Int 2001 59 : 2377.
10. Schmid T, Muller P, Spelsberg F. Parathyroidectomy after renal transplantation: a retrospective analysis of long-term outcome. Nephrol Dial Transplant 1997 12 : 2393.
11. D'alessandro A, Melzer J, Pirsch J, et al. Tertiary hyperparathyroidism after renal transplantation: operative indications. Surgery 1989 106 : 1049.
12. Douthat W, Orozco S, de Arteaga J, et al. Treatment of refractory secondary hyperparathyroidism with ethanol injection: the importance of glandular volume. Kidney Int 2003 63 (Suppl. 85 S101.
13. Fukagawa M, Kitaoka M, Tominaga Y, et al. Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients. Nephrol Dial Transplant 2003 18 (Suppl. 3 2.
14. Solbiati L, Giangrande A, Pra R, et al. Ultrasound-guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism. Radiology 1985 155 : 607.
15. Fukagawa M, Kitaoka M, Tominaga Y, et al. Selective percutaneous ethanol injection therapy (PEIT) of the parathyroid in chronic renal dialysis patients-The Japanese strategy. Nephrol Dial Transplant 1999 14 : 2574.
16. Fukagawa M, Fukuda N, Yi H, et al. Resistance of parathyroid cell to calcitriol as a cause of parathyroid hyperfunction in chronic renal failure. Nephrol Dial Transplant 1995 10 : 316.
17. Stracke S, Jehle P, Sturm D, et al. Clinical course after total parathyroidectomy without autotransplantation in patients with end-stage renal failure. Am J Kidney Dis 1999 33 : 304.
18. Schwarz A, Rustien G, Merkel S, et al. Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transplant 2007 22 : 584.
19. Block G, Martin K, de Francisco A, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Eng J Med 2004 350 : 1516.
20. Cunningham J, Danese M, Olson K, et al. Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 2005 68 : 1793.